Podcast

Listen to this podcast: Dying To Remember

Researchers at the Miller School of Medicine are testing a new drug for dementia with Lewy bodies, a disease that affects an estimated 1.4 million Americans. James Galvin, M.D., M.P.H., director of the Comprehensive Center for Brain Health at the Miller School, joins Dean Henri Ford to give insight into this devastating illness and the search for better outcomes. https://med.miami.edu/podcast/inside-umiami-medicine

Listen to this podcast below:

Gabrielle

Share
Published by
Gabrielle
1 year ago

Recent Posts

All County Health Care wants to welcome and thank Dr. James Galvin from the UMIAMI Miller School of Medicine Comprehensive Center for Brain Health located in Boca Raton

Watch the episode here: https://fb.watch/iihQ9tPX-H/

1 year ago

Dr. James E. Galvin Shares with Scripps News A New Tool Developed By Researchers Could Be Breakthrough Assessing Alzheimer’s Risk

1 year ago

Addressing Unmet Needs of Dementia With Lewy Bodies: James Galvin, MD, MPH

Watch Here: https://www.neurologylive.com/view/addressing-unmet-needs-dementia-with-lewy-bodies-james-galvin

1 year ago

Digital brain health platform offers rapid, accurate assessment of dementia risk

Click here to learn more: https://www.healio.com/news/neurology/20221117/digital-brain-health-platform-offers-rapid-accurate-assessment-of-dementia-risk

1 year ago

Efe News/Yahoo Noticias!

Científicos estadounidenses han implementado un nuevo programa de salud que proporciona herramientas para evaluar con…

1 year ago

Study: New Brain Health Platform Gives Physicians New Tools to Precisely Assess Dementia Risk

Read the article here: https://physician-news.umiamihealth.org/study-new-brain-health-platform-gives-physicians-new-tools-to-precisely-assess-dementia-risk/

1 year ago